肺功能统计的第一印象至关重要：一年就可以改变哮喘预后
2020/02/11
摘要
尽管哮喘是最频发的慢性疾病之一，但哮喘患者生活在充满希望的时代。应用吸入性糖皮质激素的规律治疗是至关重要的，可以影响并改变亿万哮喘患者的生命。新分子技术的进步，无论是单独的还是联合的，以及吸入器技术的发展和生物制剂的出现，增加了对每个哮喘患者实现疾病控制和肺功能正常化(而不是优化)的渴望。作为一个没有明确治愈标准的慢性疾病来说，用以评估临床实践结果的长期实际研究是非常必要的。
The first impression counts for lung function: one year to make a difference in asthma prognosis.
Pite H, et al. Allergy. 2019 Aug 24.
Abstract
Despite being one of the most frequent chronic diseases, asthma patients live in times of hope. The introduction of regular treatment with inhaled corticosteroids (ICS) was crucial, impacting and changing the lives of several hundred million asthmatics. Advances with new molecules, whether alone or in combination, coupled with developments in inhaler technology and the advent of biologics raise the aspiration of achieving control and normalising (as opposed to optimizing) lung function, for every asthma patient. As a chronic disease without definite cure, the need for long-term real-life studies is imperative to assess clinical practice outcomes.
尽管哮喘是最频发的慢性疾病之一，但哮喘患者生活在充满希望的时代。应用吸入性糖皮质激素的规律治疗是至关重要的，可以影响并改变亿万哮喘患者的生命。新分子技术的进步，无论是单独的还是联合的，以及吸入器技术的发展和生物制剂的出现，增加了对每个哮喘患者实现疾病控制和肺功能正常化(而不是优化)的渴望。作为一个没有明确治愈标准的慢性疾病来说，用以评估临床实践结果的长期实际研究是非常必要的。
（中国医科大学附属第一医院 李文扬 摘译 杨冬 审校）
（Pite H, et al. Allergy. 2019 Aug 24.）
（Pite H, et al. Allergy. 2019 Aug 24.）
The first impression counts for lung function: one year to make a difference in asthma prognosis.
Pite H, et al. Allergy. 2019 Aug 24.
Abstract
Despite being one of the most frequent chronic diseases, asthma patients live in times of hope. The introduction of regular treatment with inhaled corticosteroids (ICS) was crucial, impacting and changing the lives of several hundred million asthmatics. Advances with new molecules, whether alone or in combination, coupled with developments in inhaler technology and the advent of biologics raise the aspiration of achieving control and normalising (as opposed to optimizing) lung function, for every asthma patient. As a chronic disease without definite cure, the need for long-term real-life studies is imperative to assess clinical practice outcomes.
上一篇：
呼出的挥发性有机化合物能够区分嗜中性粒细胞和嗜酸性哮喘
下一篇：
肥大细胞蛋白酶在哮喘中的新作用
